Sabra Healthcare REIT (SBRA) Projected to Announce Quarterly Earnings on Monday

Key Points

• Sabra Healthcare REIT is expected to report Q3 2026 earnings after the market closes Monday, November 2. Analysts forecast EPS of $0.1637 and revenue of $236.64 million; the conference call is scheduled for November 3 at 1:00 p.m. ET.
• In its prior quarter, Sabra reported a $0.10 per-share loss, missing consensus estimates, although revenue rose 24.7% year over year to $230.11 million and exceeded expectations.
• Shares recently traded near $19.56, while the company’s $0.30 quarterly dividend equates to a 6.1% yield. Analysts maintain a “Moderate Buy” consensus with a $21.50 average price target.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) is expected to be announcing its Q3 2026 results after the market closes on Monday, November 2nd. Analysts expect Sabra Healthcare REIT to announce earnings of $0.1637 per share and revenue of $236.64 million for the quarter. Parties can find conference call details on the company's upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Tuesday, November 3, 2026 at 1:00 PM ET.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last announced its quarterly earnings results on Monday, August 3rd. The real estate investment trust reported ($0.10) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.17 by ($0.27). Sabra Healthcare REIT had a net margin of 7.61% and a return on equity of 2.34%. The company had revenue of $230.11 million during the quarter, compared to analyst estimates of $219.39 million. During the same period in the previous year, the firm posted $0.38 earnings per share. The company's revenue was up 24.7% compared to the same quarter last year. On average, analysts expect Sabra Healthcare REIT to post $1.52 EPS for the current fiscal year and $1.60 EPS for the next fiscal year.

Sabra Healthcare REIT Stock Performance

Sabra Healthcare REIT stock opened at $19.56 on Monday. The firm has a market cap of $5.00 billion, a PE ratio of 75.23, a P/E/G ratio of 1.78 and a beta of 0.63. Sabra Healthcare REIT has a 12 month low of $17.17 and a 12 month high of $22.77. The stock's 50 day simple moving average is $19.97 and its two-hundred day simple moving average is $20.06. The company has a current ratio of 3.07, a quick ratio of 3.07 and a debt-to-equity ratio of 0.95.

Sabra Healthcare REIT Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, August 31st. Stockholders of record on Friday, August 14th were issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 6.1%. The ex-dividend date of this dividend was Friday, August 14th. Sabra Healthcare REIT's payout ratio is 461.54%.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on SBRA shares. Truist Financial increased their price target on shares of Sabra Healthcare REIT from $22.00 to $24.00 and gave the stock a "buy" rating in a report on Wednesday, July 22nd. Barclays dropped their price target on shares of Sabra Healthcare REIT from $23.00 to $21.00 and set an "equal weight" rating on the stock in a research report on Tuesday, October 13th. Mizuho set a $21.00 price objective on shares of Sabra Healthcare REIT in a report on Monday, August 31st. Weiss Ratings downgraded shares of Sabra Healthcare REIT from a "hold (c+)" rating to a "hold (c)" rating in a research report on Thursday, October 8th. Finally, Deutsche Bank Aktiengesellschaft reissued a "buy" rating on shares of Sabra Healthcare REIT in a research note on Wednesday, July 22nd. Seven analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $21.50.

Insider Transactions at Sabra Healthcare REIT

In related news, CEO Richard Matros sold 200,000 shares of Sabra Healthcare REIT stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $20.83, for a total value of $4,166,000.00. Following the sale, the chief executive officer owned 1,657,686 shares of the company's stock, valued at approximately $34,529,599.38. This trade represents a 10.77% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 1.09% of the company's stock.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc is a self-managed real estate investment trust that owns and invests in healthcare-related real estate. The company focuses primarily on properties used for skilled nursing and transitional care, senior housing, behavioral health, specialty hospitals and other healthcare services.

Sabra leases properties to healthcare operators and also provides capital through loans, joint ventures and other real estate investments. Its portfolio is designed to support a range of care settings, including facilities serving seniors, patients requiring rehabilitation and individuals receiving behavioral healthcare.

Founded in 2010 and headquartered in Irvine, California, Sabra has expanded through acquisitions, development investments and strategic transactions, including its 2017 combination with Care Capital Properties.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.